BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37802701)

  • 61. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 3.0-T closed MR-guided microwave ablation for HCC located under the hepatic dome: a single-center experience.
    Xu K; Li Z; Wang C; Tian C; Jiao D; Han X; Yan Y
    Int J Hyperthermia; 2022 Dec; 39(1):1044-1051. PubMed ID: 35940593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiofrequency ablation for neuroendocrine liver metastases: a systematic review.
    Mohan H; Nicholson P; Winter DC; O'Shea D; O'Toole D; Geoghegan J; Maguire D; Hoti E; Traynor O; Cantwell CP
    J Vasc Interv Radiol; 2015 Jul; 26(7):935-942.e1. PubMed ID: 25840836
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomas.
    Tang X; Ding M; Lu B; Chi J; Wang T; Shi Y; Wang Z; Cui D; Li P; Zhai B
    Int J Hyperthermia; 2019; 36(1):632-639. PubMed ID: 31244349
    [No Abstract]   [Full Text] [Related]  

  • 65. Local Ablation for Solid Tumor Liver Metastases: Techniques and Treatment Efficacy.
    Wong J; Cooper A
    Cancer Control; 2016 Jan; 23(1):30-5. PubMed ID: 27009454
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
    Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
    J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stereotactic image-guided microwave ablation of hepatocellular carcinoma using a computer-assisted navigation system.
    Lachenmayer A; Tinguely P; Maurer MH; Frehner L; Knöpfli M; Peterhans M; Weber S; Dufour JF; Candinas D; Banz V
    Liver Int; 2019 Oct; 39(10):1975-1985. PubMed ID: 31276296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism.
    Liang PC; Lai HS; Shih TT; Wu CH; Huang KW
    BMC Surg; 2014 Oct; 14():82. PubMed ID: 25336074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Determination of surgical margins in laparoscopic parenchyma-sparing hepatectomy of neuroendocrine tumors liver metastases using indocyanine green fluorescence imaging.
    Wang G; Luo Y; Qi W; Yuan C; Xiu D
    Surg Endosc; 2022 Jun; 36(6):4408-4416. PubMed ID: 35006372
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
    Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
    AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
    [No Abstract]   [Full Text] [Related]  

  • 72. Surgical microwave ablation of otherwise non-resectable colorectal cancer liver metastases: Expanding opportunities for long term survival.
    McEachron KR; Ankeny JS; Robbins A; Altman AM; Marmor S; D'Souza D; Schat R; Spilseth B; Jensen EH
    Surg Oncol; 2021 Mar; 36():61-64. PubMed ID: 33316680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
    Gold JS; Are C; Kornprat P; Jarnagin WR; Gönen M; Fong Y; DeMatteo RP; Blumgart LH; D'Angelica M
    Ann Surg; 2008 Jan; 247(1):109-17. PubMed ID: 18156930
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term survival after surgical management of neuroendocrine hepatic metastases.
    Glazer ES; Tseng JF; Al-Refaie W; Solorzano CC; Liu P; Willborn KA; Abdalla EK; Vauthey JN; Curley SA
    HPB (Oxford); 2010 Aug; 12(6):427-33. PubMed ID: 20662794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis.
    Soliman AF; Abouelkhair MM; Hasab Allah MS; El-Kady NM; Ezzat WM; Gabr HA; Elsayed EH; Saleh AI; Kamel A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):295-301. PubMed ID: 30678453
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Percutaneous Application of High Power Microwave Ablation With 150 W for the Treatment of Tumors in Lung, Liver, and Kidney: A Preliminary Experience.
    Lanza C; Carriero S; Ascenti V; Tintori J; Ricapito F; Lavorato R; Biondetti P; Angileri SA; Piacentino F; Fontana F; Venturini M; Ierardi AM; Carrafiello G
    Technol Cancer Res Treat; 2023; 22():15330338231185277. PubMed ID: 37608585
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors: A retrospective study.
    Jiao X; Luan W; Peng X; Liu L; Zhang L; Zhou L
    Medicine (Baltimore); 2020 Dec; 99(51):e23655. PubMed ID: 33371100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oncological outcomes after hepatic resection and/or surgical microwave ablation for liver metastasis from gastric cancer.
    Ryu T; Takami Y; Wada Y; Tateishi M; Matsushima H; Yoshitomi M; Saitsu H
    Asian J Surg; 2019 Jan; 42(1):100-105. PubMed ID: 29254868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.